Cargando…
Clinical Therapeutics in Pregnancy
Most drugs are not tested for use during pregnancy, consequently, labeling, which may include information about fetal safety, includes nothing about dosing, efficacy, or maternal safety. Yet these are concerns of health care providers considering treatment of disease during pregnancy. Therefore, the...
Autores principales: | Feghali, Maisa N., Mattison, Donald R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139199/ https://www.ncbi.nlm.nih.gov/pubmed/21785566 http://dx.doi.org/10.1155/2011/783528 |
Ejemplares similares
-
Mid-pregnancy sleep disturbances are not associated with mid-pregnancy maternal glycemia
por: HAWKINS, Marquis, et al.
Publicado: (2023) -
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012) -
Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
por: Argula, Rahul G, et al.
Publicado: (2019) -
Joining Forces: Establishing a Cardio-oncology Clinic
por: Austin-Mattison, Caroline
Publicado: (2018) -
Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach()()
por: Fagundes, Patrícia Penha Silveira, et al.
Publicado: (2021)